NASDAQ$NEOG
Neogen Corporation · Q1 2022 earnings
Q1 2022 earnings · · Investor relations
Briefing
Neogen's Q1 2022 results showcased resilience with record revenue and double-digit organic sales growth in both Food Safety and Animal Safety segments.
Neogen Corporation announced record revenue of $128.305 million for the first quarter of fiscal year 2022, a 17% increase compared to the previous year. Both the Food Safety and Animal Safety segments experienced double-digit organic sales growth. Net income increased to $17.077 million, or $0.16 per share.
- Revenues increased by 17% compared to the prior year's first quarter.
- Food Safety and Animal Safety segments both achieved double-digit organic sales growth for the third consecutive quarter.
- Net income rose to $17.077 million, or $0.16 per share, compared to $15.860 million, or $0.15 per share, in the previous year.
- Gross margins improved to 46.8% due to higher margin product sales within the Food Safety segment.
Headline financials
Revenue & EPS history
Neogen · Revenue · Quarterly
$128M
Revenue by segment
Neogen · $128M total across 2 segments · Q1 2022
- Animal Safety$65.6M+18.9%51.1%
- Food Safety$62.7M+15.8%48.9%
Forward guidance
Neogen is optimistic for the remainder of the year due to strong results and excitement surrounding new Megazyme product offerings.
Tailwinds
- Strong results showcase Neogen's resilience.
- Growth across almost all core product lines.
- Tremendous excitement surrounding new Megazyme product offerings.
- Positive start to the new fiscal year.
- International operations performed well during the quarter.
Headwinds
- Challenges due to supply chain issues.
- Labor shortages.
- Higher product costs caused by the COVID-19 pandemic.
- Drug residue test kit sales declined by 22% due to the prior year termination of a European distribution agreement and competitive pressure within the marketplace.
- Revenues at the company’s Brazilian operations declined by 15%.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2022
-1.4%
Avg return
Earnings day
-2.4%
Avg return
5 days after
-1.8%
Avg return
30 days after
36%
23 / 64 earnings
Positive
+31.5%
Q2 2026
Best reaction
-28.7%
Q3 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2026 | +3.9% | -7.1% | -12.5% | |
| Q2 2026 | +31.5% | +24.5% | +46.3% | |
| Q1 2026 | +16.4% | +1.5% | +10.0% | |
| Q3 2025 | -28.7% | -23.3% | -15.2% | |
| Q2 2025 | -3.3% | -13.1% | -20.7% | |
| Q1 2025 | -2.8% | -0.8% | +9.3% | |
| Q4 2024 | -1.6% | -5.3% | -1.0% | |
| Q3 2024 | -13.1% | -13.9% | -13.6% | |
| Q2 2024 | -5.5% | -8.4% | -18.0% | |
| Q1 2024 | -11.7% | -8.8% | -11.0% | |
| Q4 2023 | +2.3% | +0.0% | +0.8% | |
| Q3 2023 | +0.2% | -3.6% | -6.9% | |
| Q2 2023 | +5.1% | +11.2% | +30.3% | |
| Q1 2023 | -1.0% | -4.1% | -12.2% | |
| Q4 2022 | +8.0% | +7.5% | -2.8% | |
| Q3 2022 | -7.4% | -5.3% | -15.3% | |
| Q2 2022 | +1.4% | +0.2% | -19.2% | |
| Q1 2022 | +3.0% | +6.1% | +2.9% | |
| Q4 2021 | +0.2% | -1.9% | -3.6% | |
| Q3 2021 | +3.0% | +5.6% | +14.9% | |
| Q2 2021 | +1.2% | +0.5% | +3.8% | |
| Q1 2021 | +0.2% | +1.1% | -4.3% | |
| Q4 2020 | -4.0% | -4.0% | -2.9% | |
| Q3 2020 | -5.3% | -1.2% | +8.1% | |
| Q2 2020 | -5.4% | -5.7% | +1.2% | |
| Q1 2020 | -10.6% | -13.0% | -13.1% | |
| Q4 2019 | +9.0% | +10.6% | +13.2% | |
| Q3 2019 | -8.3% | -5.2% | -4.4% | |
| Q2 2019 | -8.1% | -10.7% | +2.4% | |
| Q1 2019 | -17.8% | -19.3% | -30.4% | |
| Q4 2018 | +1.5% | +1.7% | +3.9% | |
| Q3 2018 | -4.2% | +1.0% | +7.6% | |
| Q2 2018 | -0.8% | -0.7% | -1.8% | |
| Q1 2018 | -4.4% | -1.5% | +6.4% | |
| Q4 2017 | -2.2% | -1.8% | -4.5% | |
| Q3 2017 | -5.9% | -6.7% | -9.8% | |
| Q2 2017 | +3.8% | +5.6% | +0.5% | |
| Q1 2017 | -4.7% | -2.8% | -10.1% | |
| Q4 2016 | -1.6% | -1.8% | -0.4% | |
| Q3 2016 | -14.6% | — | — | |
| Q2 2016 | -2.0% | — | — | |
| Q1 2016 | -12.1% | — | — | |
| Q4 2015 | +25.2% | — | — | |
| Q3 2015 | -3.4% | — | — | |
| Q2 2015 | +1.2% | — | — | |
| Q1 2015 | -1.7% | — | — | |
| Q4 2014 | +11.3% | — | — | |
| Q3 2014 | -0.1% | — | — | |
| Q2 2014 | -5.6% | — | — | |
| Q1 2014 | -0.3% | — | — | |
| Q4 2013 | -4.9% | — | — | |
| Q3 2013 | +0.5% | — | — | |
| Q2 2013 | -0.7% | — | — | |
| Q1 2013 | +7.5% | — | — | |
| Q4 2010 | -2.9% | — | — | |
| Q4 2012 | -2.9% | — | — | |
| Q3 2012 | -0.3% | — | — | |
| Q3 2011 | -0.3% | — | — | |
| Q2 2011 | +2.5% | — | — | |
| Q2 2012 | +2.5% | — | — | |
| Q4 2011 | -7.3% | — | — | |
| Q1 2011 | -7.3% | — | — | |
| Q1 2012 | -7.3% | — | — | |
| Q3 2010 | -0.5% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro